Literature DB >> 14579350

Assessment of progress over the CASP experiments.

Ceslovas Venclovas1, Adam Zemla, Krzysztof Fidelis, John Moult.   

Abstract

The quality of structure models produced in the CASP5 experiment has been compared with that in earlier CASPs. The most significant progress is in the fold recognition regime, where the development of meta-servers has allowed more accurate consensus models to be generated. In contrast to this, there is little evidence of progress in producing more accurate comparative models, particularly those based on sequence identities > 30%. For comparative models based on low-sequence identity and for fold recognition models, accuracy depends primarily on the fraction of the target structure that is similar to an available template, and the quality of the alignment. Overall, these results indicate that there are still no effective methods of improving model quality beyond that obtained by successfully copying a template structure. For models of proteins with previously unknown folds, there appears to be a pause in the previous consistent improvement. There is some evidence that more groups are producing top-quality models, however. Although specific progress between successive experiments is sometimes difficulty to identify, over the history of all the CASPs there has been steady, if sometimes slow, progress in all modeling regimes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579350     DOI: 10.1002/prot.10530

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  39 in total

1.  Scoring profile-to-profile sequence alignments.

Authors:  Guoli Wang; Roland L Dunbrack
Journal:  Protein Sci       Date:  2004-06       Impact factor: 6.725

2.  Assessing predictions of protein-protein interaction: the CAPRI experiment.

Authors:  Joël Janin
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

3.  Computational thermostabilization of an enzyme.

Authors:  Aaron Korkegian; Margaret E Black; David Baker; Barry L Stoddard
Journal:  Science       Date:  2005-05-06       Impact factor: 47.728

4.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

5.  High-resolution protein folding with a transferable potential.

Authors:  Isaac A Hubner; Eric J Deeds; Eugene I Shakhnovich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 6.  Advances in homology protein structure modeling.

Authors:  Zhexin Xiang
Journal:  Curr Protein Pept Sci       Date:  2006-06       Impact factor: 3.272

7.  On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins.

Authors:  Lucy R Forrest; Christopher L Tang; Barry Honig
Journal:  Biophys J       Date:  2006-04-28       Impact factor: 4.033

8.  Microparadigms: chains of collective reasoning in publications about molecular interactions.

Authors:  Andrey Rzhetsky; Ivan Iossifov; Ji Meng Loh; Kevin P White
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-16       Impact factor: 11.205

Review 9.  Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery.

Authors:  Tom L Blundell; Bancinyane L Sibanda; Rinaldo Wander Montalvão; Suzanne Brewerton; Vijayalakshmi Chelliah; Catherine L Worth; Nicholas J Harmer; Owen Davies; David Burke
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-03-29       Impact factor: 6.237

10.  Solvent dramatically affects protein structure refinement.

Authors:  Gaurav Chopra; Christopher M Summa; Michael Levitt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.